Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer

被引:198
|
作者
Walker, Joan L. [1 ]
Powell, C. Bethan [2 ]
Chen, Lee-may [3 ]
Carter, Jeanne [4 ]
Jump, Victoria L. Bae [5 ]
Parker, Lynn P. [6 ]
Borowsky, Mark E. [7 ]
Gibb, Randall K. [8 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK 73104 USA
[2] Kaiser Permanente San Francisco, Northern Calif Gynecol Canc Program, San Francisco, CA USA
[3] Univ Calif San Francisco, Mt Zion Canc Ctr, Div Gynecol Oncol, San Francisco, CA 94143 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA
[5] Univ N Carolina, Div Gynecol Oncol, Chapel Hill, NC USA
[6] Norton Canc Inst, Louisville, KY USA
[7] Christiana Care Hlth Syst, Helen F Graham Canc Ctr, Newark, DE USA
[8] Billings Clin, Ctr Canc, Billings, MT USA
关键词
BRCA; carriers; Cascade genetic testing; fallopian tube; genetic testing; mastectomy; ovarian cancer; oral contraceptives; prevention; salpingectomy; risk-reducing bilateral salpingo-oophorectomy (BSO); REDUCING SALPINGO-OOPHORECTOMY; BRCA MUTATION CARRIERS; QUALITY-OF-LIFE; FALLOPIAN-TUBE EPITHELIUM; PELVIC SEROUS CARCINOMA; ORAL-CONTRACEPTIVE USE; HIGH-RISK WOMEN; PROPHYLACTIC SALPINGECTOMY; BREAST-CANCER; LAPAROSCOPIC SALPINGECTOMY;
D O I
10.1002/cncr.29321
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mortality from ovarian cancer may be dramatically reduced with the implementation of attainable prevention strategies. The new understanding of the cells of origin and the molecular etiology of ovarian cancer warrants a strong recommendation to the public and health care providers. This document discusses potential prevention strategies, which include 1) oral contraceptive use, 2) tubal sterilization, 3) risk-reducing salpingo-oophorectomy in women at high hereditary risk of breast and ovarian cancer, 4) genetic counseling and testing for women with ovarian cancer and other high-risk families, and 5) salpingectomy after childbearing is complete (at the time of elective pelvic surgeries, at the time of hysterectomy, and as an alternative to tubal ligation). The Society of Gynecologic Oncology has determined that recent scientific breakthroughs warrant a new summary of the progress toward the prevention of ovarian cancer. This review is intended to emphasize the importance of the fallopian tubes as a potential source of high-grade serous cancer in women with and without known genetic mutations in addition to the use of oral contraceptive pills to reduce the risk of ovarian cancer. Cancer 2015;121:2108-2120. (c) 2015 American Cancer Society.
引用
收藏
页码:2108 / 2120
页数:13
相关论文
共 50 条
  • [1] Society of Gynecologic Oncology Recommendations for the Prevention of Ovarian Cancer
    Walker, Joan L.
    Powell, C. Bethan
    Chen, Lee-May
    Carter, Jeanne
    Jump, Victoria L. Bae
    Parker, Lynn P.
    Borowsky, Mark E.
    Gibb, Randall K.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2015, 70 (07) : 448 - 449
  • [2] Informed consent forms for gynecologic cancer surgery: recommendations from the Korean Society of Gynecologic Oncology
    Chang, Ha Kyun
    Shim, Seung-Hyuk
    Lee, Maria
    Lee, Won Moo
    Eoh, Kyung Jin
    Yoo, Heon Jong
    Kim, Mi Kyung
    Kim, Min Kyu
    Lee, Kwang-Beom
    So, Kyeong A.
    Kim, Young Tae
    Lee, Dae Woo
    Hyun, Doo-Yoon
    Lee, Jong-Min
    OBSTETRICS & GYNECOLOGY SCIENCE, 2022, 65 (02) : 105 - 112
  • [3] Informed consent forms for gynecologic cancer surgery: recommendations from the Korean Society of Gynecologic Oncology
    Chang, Ha Kyun
    Shim, Seung-Hyuk
    Lee, Maria
    Lee, Won Moo
    Eoh, Kyung Jin
    Yoo, Heon Jong
    Kim, Mi Kyung
    Kim, Min Kyu
    Lee, Kwang-Beom
    So, Kyeong A.
    Kim, Young Tae
    Lee, Dae Woo
    Hyun, Doo-Yoon
    Lee, Jong-Min
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2022, 33 (02)
  • [4] Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines
    Lee, Banghyun
    Chang, Suk-Joon
    Kwon, Byung Su
    Son, Joo-Hyuk
    Lim, Myong Cheol
    Kim, Yun Hwan
    Lee, Shin-Wha
    Choi, Chel Hun
    Eoh, Kyung Jin
    Lee, Jung-Yun
    Suh, Dong Hoon
    Kim, Yong Beom
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (01)
  • [5] Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations
    Hamilton, Chad A.
    Pothuri, Bhavana
    Arend, Rebecca C.
    Backes, Floor J.
    Gehrig, Paola A.
    Soliman, Pamela T.
    Thompson, J. Spencer
    Urban, Renata R.
    Burke, William M.
    GYNECOLOGIC ONCOLOGY, 2021, 160 (03) : 817 - 826
  • [6] Will ovarian transposition become the forceps of gynecologic oncology? A survey of the Society of Gynecologic Oncology members
    Gordhandas, Sushmita
    Kahn, Ryan
    Broach, Vance
    Leitao, Mario
    Roche, Kara Long
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S249 - S249
  • [7] Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper
    Herzog, Thomas J.
    Armstrong, Deborah K.
    Brady, Mark F.
    Coleman, Robert L.
    Einstein, Mark H.
    Monk, Bradley J.
    Mannel, Robert S.
    Thigpen, J. Tate
    Umpierre, Sharee A.
    Villella, Jeannine A.
    Alvarez, Ronald D.
    GYNECOLOGIC ONCOLOGY, 2014, 132 (01) : 8 - 17
  • [8] Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines
    Lee, Banghyun
    Chang, Suk-Joon
    Kwon, Byung Su
    Son, Joo-Hyuk
    Lim, Myong Cheol
    Kim, Yun Hwan
    Lee, Shin-Wha
    Choi, Chel Hun
    Eoh, Kyung Jin
    Lee, Jung-Yun
    Lee, Yoo-Young
    Suh, Dong Hoon
    Kim, Yong Beom
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2025, 36 (01)
  • [9] Ovarian cancer; Will the new challenge in gynecologic oncology?
    Cantu de Leon, David
    Mohar, Alejandro
    Herrera, Luis A.
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2011, 63 (06): : 555 - 557
  • [10] The Gynecologic Oncology Group experience in ovarian cancer
    McGuire, WP
    Brady, MF
    Ozols, RF
    ANNALS OF ONCOLOGY, 1999, 10 : 29 - 34